Skip to content Skip to footer

RION Launches RION Vet to Advance Platelet-Derived Biologics in Animal Health

Shots: RION has launched RION Vet, a veterinary biotechnology subsidiary, with exclusive global rights to RION’s exosome-based therapeutic platform for animal health RION Vet is developing ePEP-01, a cell-free, shelf-stable platelet-derived biologic, for equine musculoskeletal disorders, which was evaluated in over 50 horses for >4yrs., showing improvement in lameness, with favorable safety RION Vet leverages…

Read more

PharmaShots Magazine-July-2025 Edition

Regenerative medicine holds a promising potential in addressing unmet medical needs and bridging the gaps in healthcare. Regenerative medicine aims to provide innovative ways to repair, rejuvenate, and replace damaged tissues and organs. Regenerative medicine is widely explored in clinical settings as cellular therapies, extracellular vesicle therapies, immune cellular therapies, and tissue-engineered grafts to prevent…

Read more